Literature DB >> 27515113

Is thyroid function associated with masked hypertension?

İhsan Ateş1, Mustafa Altay2, Mustafa Kaplan2, Mehmet Fettah Arıkan2, Nihal Özkayar3, Mehmet Erdem Alagüney2, Fatih Dede3, Adem Özkara4.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27515113      PMCID: PMC5368533          DOI: 10.14744/AnatolJCardiol.2016.7197

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN: 2149-2263            Impact factor:   1.596


× No keyword cloud information.
To the Editor, Masked hypertension (MHT) was first defined by Pickering in 1992, and its importance is progressively increasing (1). MHT is a condition wherein blood pressure measured according to hypertension guidelines in office is normal, whereas the mean 24-h ambulatory blood pressure measurement or blood pressure measurement out of office is high (2). Studies relating to the etiology of MHT is limited, and possible etiological factors include work stress, smoking, alcohol use, male sex, and excessive physical activity (3, 4). The association between MHT and thyroid hormone, which has major effects on the cardiovascular system, is not known. This study aims to investigate the association between thyroid hormone and blood pressure in newly diagnosed MHT patients. In total, 712 patients without a previous diagnosis of hypertension and who were admitted to the outpatient clinic with hypertensive symptoms were enrolled. Patients were categorized into three groups, MHT, primary hypertension (PHT), and normotensive, according to the blood pressures measured at home and at the hospital. The mean systolic blood pressure (SBP) measured in office was <140 mm Hg and the mean diastolic blood pressure (DBP) was <90 mm Hg, whereas the mean measurements made at home were >135 mm Hg and >85 mm Hg, respectively; with these values, a diagnosis of MHT was made (2). Thyroid stimulating hormone (TSH), free-thyroxine (fT4), and free-triiodothyronine (fT3) levels were evaluated in 73 MHT, 73 PHT, and 74 normotensive participants using electrochemiluminescence immunoassay. The measurement device (Omron-M3, Omron-Healthcare Co. Ltd., Tokyo, Japan) was given to the participants, and they were instructed to measure blood pressure for 7 days, twice a day (2). Of the 712 participants included in study, PHT in 206 patients, MHT in 73 patients, and normotension in 433 patients were determined. The mean SBP and DBP of patients with MHT and PHT were similar, whereas the mean SBP and DBP of the normotensive group were lower than those of the hypertensive groups. The mean log (TSH) level was higher, whereas the mean fT4 level was lower in the PHT group as compared with the MHT and normotensive groups. Log (TSH) and fT4 levels were similar in the MHT and normotensive groups. The proportion of patients with hypothyroidism was higher in the PHT group as compared with the other groups (PHT: 17.8% vs MHT: 1.4% vs normotensive: 5.4%). Stepwise multiple regression analysis showed that mean SBP and DBP are associated with log (TSH), fT4, and presence of hypothyroidism in the PHT group. Such associations were not found in MHT and normotensive groups. No associations were determined between patients with MHT and thyroid hormone. The finding that there was no association between MHT and thyroid hormone can be interpreted in two ways. First, the risk factors effective in the pathophysiology of MHT increase blood pressure independent of the levels of thyroid hormone. This hypothesis is supported by the fact that blood pressure increases during work stress and related etiological factors and is regulated during rest in patients with MHT (4). Second, thyroid hormone dysfunction may not cause MHT pattern (out of office) of high blood pressure and instead may lead to persistent hypertension pattern of high blood pressure. This abstract was presented as a poster presentation in the European Society of Endocrinology Congress (Dublin, 2015).
  4 in total

1.  What stands behind masked hypertension?

Authors:  Bernard Waeber
Journal:  J Hypertens       Date:  2008-09       Impact factor: 4.844

2.  Relation between job strain, alcohol, and ambulatory blood pressure.

Authors:  P L Schnall; J E Schwartz; P A Landsbergis; K Warren; T G Pickering
Journal:  Hypertension       Date:  1992-05       Impact factor: 10.190

3.  Relationship between socioeconomic level, and the prevalence of masked hypertension and asymptomatic organ damage.

Authors:  İhsan Ateş; Mustafa Altay; Mustafa Kaplan; Nihal Ozkayar; Güvenc Toprak; M Erdem Alagüney; Adem Özkara
Journal:  Med Sci Monit       Date:  2015-04-08

4.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.